Concepedia

David P. Hesson

DP

Statistics

Publications

13

Citations

1.3K

H-Index

12

Active since

1975

Affiliations

DuPont (United States)(Current)

University of Michigan

Yale University

Sterling Research Group

David P. Hesson is an author at DuPont (United States) specializing in medicinal chemistry, pharmacology, and medicine.

Publications per year

1975–2018

13

Publications

13

TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P

Lynne A. Murray, Qingsheng Chen, Michael S. Kramer et al. · The International Journal of Biochemistry & Cell Biology · 2010 · 361 citations

, , +14

Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization

Jack B. Jiang, David P. Hesson, Betsy A. Dusak et al. · Journal of Medicinal Chemistry · 1990 · 261 citations

, , +14

Serum Amyloid P Therapeutically Attenuates Murine Bleomycin-Induced Pulmonary Fibrosis via Its Effects on Macrophages

Lynne A. Murray, Rogério Silva Rosada, Ana Paula Moreira et al. · PLoS ONE · 2010 · 192 citations · Full text

, , +17

Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors.

Daniel L. Dexter, David P. Hesson, Robert Ardecky et al. · PubMed · 1985 · 104 citations

, , +12

Substituted 1,2-Dihydrophthalazines:  Potent, Selective, and Noncompetitive Inhibitors of the AMPA Receptor

Jeffrey C. Pelletier, David P. Hesson, Kenneth A. Jones et al. · Journal of Medicinal Chemistry · 1996 · 94 citations

, , +10

1–5 of 13